Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Kapp

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cytotherapy|March 14, 2013
Stimulating surface molecules, Th1-polarizing cytokines, proven trafficking--a new protocol for the generation of clinical-grade dendritic cellsSen Mui Tan, Markus Kapp, Christin Flechsig, et al.
Leukemia & Lymphoma|May 28, 2015
Control of relapsed or refractory acute myeloid leukemia by clofarabine in preparation for allogeneic stem cell transplantClaudia Loeffler, Markus Kapp, Goetz-Ulrich Grigoleit, et al.
International Journal of Colorectal Disease|March 22, 2012
Prevention of major infectious complications by pre-emptive enterostomy in patients awaiting allogeneic stem cell transplantationMarkus Kapp, Götz Ulrich Grigoleit, Ulrich A Dietz, et al.
Annals of Hematology|April 23, 2015
MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantationCiprian Tomuleasa, Shigeo Fuji, Andrei Cucuianu, et al.
Journal of Medical Microbiology|December 17, 2008
Interaction analyses of human monocytes co-cultured with different forms of Aspergillus fumigatusJuergen Loeffler, Ziad Haddad, Michael Bonin, et al.
Cancer Immunology, Immunotherapy : CII|November 30, 2016
Targeting of the WT1<sub>91-138</sub> fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccinationNergui Dagvadorj, Anne Deuretzbacher, Daniela Weisenberger, et al.
Clinical and Vaccine Immunology : CVI|August 14, 2009
Immune responses of human immature dendritic cells can be modulated by the recombinant Aspergillus fumigatus antigen Aspf1Michael Ok, Jean Paul Latgé, Carina Baeuerlein, et al.
Cancers|October 13, 2021
<i>MET</i> Amplification in Non-Small Cell Lung Cancer (NSCLC)-A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World SettingChristoph Schubart, Robert Stöhr, Lars Tögel, et al.
Cancer Medicine|June 14, 2021
Preinfection laboratory parameters may predict COVID-19 severity in tumor patientsAlexander Kiani, Romina Roesch, Clemens M Wendtner, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cytotherapy|March 14, 2013
Stimulating surface molecules, Th1-polarizing cytokines, proven trafficking--a new protocol for the generation of clinical-grade dendritic cellsSen Mui Tan, Markus Kapp, Christin Flechsig, et al.
Leukemia & Lymphoma|May 28, 2015
Control of relapsed or refractory acute myeloid leukemia by clofarabine in preparation for allogeneic stem cell transplantClaudia Loeffler, Markus Kapp, Goetz-Ulrich Grigoleit, et al.
International Journal of Colorectal Disease|March 22, 2012
Prevention of major infectious complications by pre-emptive enterostomy in patients awaiting allogeneic stem cell transplantationMarkus Kapp, Götz Ulrich Grigoleit, Ulrich A Dietz, et al.
Annals of Hematology|April 23, 2015
MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantationCiprian Tomuleasa, Shigeo Fuji, Andrei Cucuianu, et al.
Journal of Medical Microbiology|December 17, 2008
Interaction analyses of human monocytes co-cultured with different forms of Aspergillus fumigatusJuergen Loeffler, Ziad Haddad, Michael Bonin, et al.
Cancer Immunology, Immunotherapy : CII|November 30, 2016
Targeting of the WT1<sub>91-138</sub> fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccinationNergui Dagvadorj, Anne Deuretzbacher, Daniela Weisenberger, et al.
Clinical and Vaccine Immunology : CVI|August 14, 2009
Immune responses of human immature dendritic cells can be modulated by the recombinant Aspergillus fumigatus antigen Aspf1Michael Ok, Jean Paul Latgé, Carina Baeuerlein, et al.
Cancers|October 13, 2021
<i>MET</i> Amplification in Non-Small Cell Lung Cancer (NSCLC)-A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World SettingChristoph Schubart, Robert Stöhr, Lars Tögel, et al.
Cancer Medicine|June 14, 2021
Preinfection laboratory parameters may predict COVID-19 severity in tumor patientsAlexander Kiani, Romina Roesch, Clemens M Wendtner, et al.
Pageof 3